Cognitive Self-Efficacy Questionna… for Parkinson's (NCT07488377)

Assess confidence in thinking skills

Trial ID
NCT07488377
Official Title
Validity and Reliability of the Turkish Version of the Cognitive Self-Efficacy Questionnaire in Individuals With Parkinson's Disease
Goal
Assess confidence in thinking skills
Status
RECRUITING
Sponsor
Acibadem University
Study Type
OBSERVATIONAL
Enrollment
100 participants
Conditions
Parkinson Disease
Interventions
Cognitive Self-Efficacy Questionnaire (Turkish Version)

Summary For Families

Researchers are checking whether a Turkish version of the Cognitive Self-Efficacy Questionnaire gives accurate and consistent information about how confident people with Parkinson's feel about their thinking and memory. Adults who come to the Movement Disorders Outpatient Clinic will complete the Turkish questionnaire during study assessments, and the researchers will analyze the answers to judge how well the tool works. The study is looking for people aged 40 to 85 with early to mid-stage Parkinson's (stage 1 to 3), a score of 24 or higher on the mini-mental state exam (a brief thinking and memory test), who can communicate, complete assessments, and give written consent; people with major depression, psychosis, advanced dementia, or severe vision or hearing problems are not eligible.

Locations

  • Acibadem University, Istanbul, Turkey, Turkey (Türkiye)

Frequently Asked Questions

What is this trial testing?
This trial is studying Cognitive Self-Efficacy Questionnaire (Turkish Version). Researchers are checking whether a Turkish version of the Cognitive Self-Efficacy Questionnaire gives accurate and consistent information about how confident people with Parkinson's feel about their thinking and memory. Adults who come to the Movement Disorders Outpatient Clinic will complete the Turkish questionnaire during study assessments, and the researchers will analyze the answers to judge how well the tool works. The study is looking for people aged 40 to 85 with early to mid-stage Parkinson's (stage 1 to 3), a score of 24 or higher on the mini-mental state exam (a brief thinking and memory test), who can communicate, complete assessments, and give written consent; people with major depression, psychosis, advanced dementia, or severe vision or hearing problems are not eligible.
Who can participate?
Participants must be between 40 Years and 85 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
How long does the trial last?
This trial is estimated to last approximately 9 months.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
Will I get a placebo in this trial?
This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
What procedures are involved in this trial?
Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.

Related Reading

View on ClinicalTrials.gov